The Program Covers 9/11 Mesothelioma and Is Authorized to 2090. The Count of Certified Cases Is Published Nowhere.

The World Trade Center Health Program covers mesothelioma. It is authorized, by its own public statement, until 2090. What no one publishes is how many 9/11 mesothelioma cases it has actually certified.

That gap is the story. Not a funding headline, because the funding headline the previous version of this report ran with does not survive contact with the primary record.

The CDC program’s public conditions page lists mesothelioma among its certified WTC-related cancers. Its public About page states it serves over 125,000 9/11 responders and survivors and is authorized until 2090. Those facts are verifiable. The number that would make this an investigation rather than a description, how many of those 125,000-plus members have a certified mesothelioma, is published nowhere: not on the program’s quarterly statistics summary, not in any agency report, not in the peer-reviewed literature, where the only 9/11-mesothelioma-specific publication is a single four-patient case series from 2024.

The Funding Claim That Could Not Be Verified

The prior version of this article was built around a specific event: a federal spending bill, signed February 3, 2026, securing the program “through 2040” with a 7% automatic annual increase, a fund rollover, and a mandated three-year cost report. A funding law was in fact enacted that day, the Consolidated Appropriations Act, 2026 (Public Law 119-75), but what it actually did was change the formula for the program’s annual appropriation to track enrollment trends instead of a consumer price index increase. The “through 2040,” “7% automatic annual increase,” fund-rollover, and three-year-report specifics are not in that law, and none of them could be verified against the enacted text or the Congressional Record.

The rest of the verifiable funding record is older. The program was established by the 2010 James Zadroga 9/11 Health and Compensation Act (Public Law 111-347) and reauthorized in 2015 (Public Law 114-113), the source of the program’s own stated 2090 horizon. The Section 1851 provision titled “Flexibility and funding for the World Trade Center Health Program” sits in the National Defense Authorization Act for Fiscal Year 2024 (Public Law 118-31, enacted December 22, 2023), Division E, Subtitle D.

A formula change is not a dated “secured through 2040” guarantee. A health-and-safety publication cannot assert a funding horizon and a specific percentage formula it cannot point to in primary law. Every “2040,” “7%,” fund-rollover, and three-year-report claim has been removed, along with a year-by-year enrollment series that rose to roughly 140,000 against the program’s own public figure of “over 125,000,” and a quotation attributed to a 2026 funding action that no primary source contains.

What Is Actually Verifiable

Strip the unverifiable funding narrative and a smaller, true picture remains. Mesothelioma is a certified WTC-related cancer. The program serves over 125,000 members and states it is authorized to 2090. Eligibility was expanded by a final rule for Pentagon and Shanksville responders published May 27, 2025.

Certification of a cancer requires the program’s documented 9/11 exposure criteria and a stated minimum-latency requirement. This report does not put a number on that latency, because the specific figure lives in the program Member Handbook and could not be verified against a primary source in this pass. Asserting a latency-years figure that is not primary-confirmed would repeat the failure this rewrite exists to correct.

The asbestos pathway itself is well documented in general terms: the towers carried sprayed asbestos fireproofing in their lower floors, and the collapse and Ground Zero recovery produced a documented dust-exposure environment. ATSDR puts mesothelioma latency at 20 to 50 years. Applied to a 2001 to 2002 exposure window, that is arithmetic on a known date, which is why it is context here and not a quantified projection.

The Gap That Is the Finding

The honest center of this story is an absence. A federal program explicitly covers 9/11 mesothelioma. It reports a large membership and a long authorization. And yet there is no published figure, anywhere in the primary record, for how many mesothelioma cases that program has certified among its members.

The only peer-reviewed evidence specific to 9/11 mesothelioma is a four-patient case series from 2024, two peritoneal and two pleural. A four-patient series is a clinical observation, not an incidence measure. It cannot tell a 9/11 responder how common this is in their cohort, because no one has published that.

That is the accountable question this investigation can actually pose: not whether the program is funded to some particular year, but why the certified mesothelioma count for the 9/11 cohort is not in any public dataset, when the cohort, the exposure, and the coverage are all documented. The Navy shipyard FOIA cohort and Texas military base investigations describe the same shape of problem: a documented exposed population whose asbestos-disease toll the government records in fragments it does not add up. The deeper 9/11 first-responder mesothelioma coverage carries the program-eligibility detail for people navigating it now.